Printer friendly version Share

News Release

Patients with aberrations in two genes respond better to drugs blocking a well-known cancer pathway

06 November 2012 The European CanCer Organisation (ECCO)

Please login or register to view articles older than 3 months

Cambridge blue millet expertsvar 2015 New Norwegian logo Elhuyar with Basque FNSF ad eNEWS Aug 2016 Science Daily